New decision aid aims to improve opioid treatment choices
NCT ID NCT03568552
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a patient decision aid designed to help adults with opioid use disorder choose the best medication-assisted treatment for them. Over 7,500 people took part, and researchers tracked their drug use, treatment retention, and health outcomes for up to 24 months. The goal was to see if the tool improves treatment success and reduces opioid use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCLA Integrated Substance Abuse Programs
Los Angeles, California, 90049, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tool better measure opioid withdrawal?
- Giving patients a voice in methadone care: a new approach under the microscope
- Can a sleep pill boost success in opioid treatment?
- Can coaching clinics curb HIV? a new strategy puts it to the test
- Could a trip to the pediatrician help teens beat opioid addiction?
- A nose spray before treatment: could naloxone speed up opioid recovery for fentanyl users?